| MK-0822 |
| N-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4’-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide |
| (CAS 603139-19-1) |
 |
| Description： |
Odanacatib (MK 0822) is an inhibitor of cathepsin K with potential anti-osteoporotic activity.
In vitro, Odanacatib shows the high inhibitory activity and selectivity on cathepsin K with IC50 values of 0.2 nM and 1 nM for human cathepsin K and rabbit cathepsin K, respectively. Furthermore, Odanacatib also shows similar potencies in whole human cell enzyme occupancy assays with corrected IC50 of 5 nM. A recent study shows that Odanacatib results in reduction of Osteoclast (OC) resorption activity by interrupting intracellular vesicular trafficking. |
| Product No. |
KT00558 |
| Product Name |
MK-0822 |
| Synonyms |
Odanacatib |
| Formal Name |
N-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4’-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide |
| CAS Number |
603139-19-1 |
| Molecular Formula |
C25H27F4N3O3S |
| Formula Weight |
525.56 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Balicatib
Cathepsin S inhibitor
E-64
Aloxistatin
PD 151746
MG-132
Bortezomib (PS-341)
Carfilzomib (PR-171)
ONX-0914 (PR-957)
MLN9708 |
|
